Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease

Tuesday, June 22, 2010 Research News
Email Print This Page Comment bookmark
Font : A-A+

Contacts:

Neurologix

Marc Panoff, 201-592-6451

Chief Financial Officer

[email protected]

Cohn & Wolfe

Jennifer Paganelli, 347-658-8290

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store